| scholarly article | Q13442814 |
| P356 | DOI | 10.1038/NRNEUROL.2013.174 |
| P698 | PubMed publication ID | 23979526 |
| P2093 | author name string | Sean I Savitz | |
| Waldo R Guerrero | |||
| P2860 | cites work | The benefits and harms of intravenous thrombolysis with recombinant tissue plasminogen activator within 6 h of acute ischaemic stroke (the third international stroke trial [IST-3]): a randomised controlled trial | Q24595579 |
| Tissue plasminogen activator for acute ischemic stroke | Q29619377 | ||
| Guidelines for the early management of patients with acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association | Q29620546 | ||
| Ninety-day outcome rates of a prospective cohort of consecutive patients with mild ischemic stroke | Q30422705 | ||
| Long-term functional recovery after first ischemic stroke: the Northern Manhattan Study | Q33697952 | ||
| Safety of tPA in stroke mimics and neuroimaging-negative cerebral ischemia. | Q33874850 | ||
| Zero on the NIHSS does not equal the absence of stroke. | Q34137039 | ||
| Methodology of the Interventional Management of Stroke III Trial | Q34672825 | ||
| The combined approach to lysis utilizing eptifibatide and rt-PA in acute ischemic stroke: the CLEAR stroke trial | Q36986795 | ||
| Efficacy and safety of tissue plasminogen activator 3 to 4.5 hours after acute ischemic stroke: a metaanalysis. | Q37301824 | ||
| Alteplase at 0.6 mg/kg for acute ischemic stroke within 3 hours of onset: Japan Alteplase Clinical Trial (J-ACT). | Q42687753 | ||
| Safety and outcome after thrombolysis in stroke patients with mild symptoms | Q43477958 | ||
| Safety and outcomes of intravenous thrombolysis in stroke mimics: a 6-year, single-care center study and a pooled analysis of reported series. | Q43761134 | ||
| NXY-059 for the treatment of acute stroke: pooled analysis of the SAINT I and II Trials | Q46680379 | ||
| Very mild stroke patients benefit from intravenous tissue plasminogen activator without increase of intracranial hemorrhage | Q47397512 | ||
| Does mild deficit for patients with stroke justify the use of intravenous tissue plasminogen activator? | Q47405212 | ||
| Utilization of intravenous tissue plasminogen activator for acute ischemic stroke | Q47945527 | ||
| Do lacunar strokes benefit from thrombolysis? Evidence from the Registry of the Canadian Stroke Network | Q48257270 | ||
| Why are stroke patients excluded from TPA therapy? An analysis of patient eligibility | Q48903469 | ||
| Outcomes in mild or rapidly improving stroke not treated with intravenous recombinant tissue-type plasminogen activator: findings from Get With The Guidelines-Stroke | Q48909644 | ||
| The albumin in acute stroke trial (ALIAS); design and methodology | Q48966295 | ||
| Reasons for exclusion from thrombolytic therapy following acute ischemic stroke. | Q49023332 | ||
| The unchanging incidence and case-fatality of stroke in the 1990s: a population-based study | Q50788189 | ||
| Outcome of stroke with mild or rapidly improving symptoms. | Q53470191 | ||
| Should You Thrombolyze All or Any Stroke Patients with Baseline National Institutes of Health Stroke Scale Scores ≤5? | Q57602744 | ||
| Early MRI and outcomes of untreated patients with mild or improving ischemic stroke | Q61891150 | ||
| Recombinant tissue plasminogen activator for minor strokes: the National Institute of Neurological Disorders and Stroke rt-PA Stroke Study experience | Q81124341 | ||
| Poor outcomes in patients who do not receive intravenous tissue plasminogen activator because of mild or improving ischemic stroke | Q81322239 | ||
| The impact of mild stroke on meaningful activity and life satisfaction | Q81371128 | ||
| Good outcomes in ischemic stroke patients treated with intravenous thrombolysis despite regressing neurological symptoms | Q82928161 | ||
| What is a minor stroke? | Q83039467 | ||
| P433 | issue | 11 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | thrombolysis | Q1931577 |
| P304 | page(s) | 653-656 | |
| P577 | publication date | 2013-08-27 | |
| P1433 | published in | Nature Reviews Neurology | Q2079285 |
| P1476 | title | Mild acute ischaemic stroke--the case for thrombolytic therapy | |
| P478 | volume | 9 |
Search more.